Recent Patents on AntiCancer Drug Discovery

Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
FOR REVIEWERS
CONTENTS & ABSTRACTS
CONTACT US

Wednesday, March 22, 2017

Most Accessed Article: Mapping the Technological Knowledge Landscape: The Case of Epigenetics

4:27 AM No comments

Most Accessed Article: Mapping the Technological Knowledge Landscape: The Case of Epigenetics

Thursday, March 16, 2017

Call For Paper

11:32 PM No comments

Call For Paper

Wednesday, March 8, 2017

Free Trial Request

10:37 PM No comments

Free Trial Request

Wednesday, March 1, 2017

Open Access Article: Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

10:33 PM No comments

Open Access Article: Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

Newer Posts Older Posts Home

Social Profiles

Popular
Tags
Blog Archives

Call For Paper

Call For Paper
Issue Publish Recent Patents on Anti-Cancer Drug Discovery

New Issue Publish Recent Patents on Anti Cancer Dru Discovery Vol. 11 Issue 4.
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women

Author(s): Zsuzsanna SubaPages 154-167 (14) Abstract: Literary data suggest apparently ambiguous interaction between menopausal status...
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery

Author(s): Zsuzsanna SubaPages 1-13 (13) Abstract: Background. Results of long-term studies justify that the rate of breast cancer rec...
Free Trial Request

Free Trial Request
Free Trial Offer

Free Trial Offer
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "

Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
Highlighted Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery

Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conse...
Call For Paper

Bentham Science Publishers would like to invite you to submit your research paper for publishing in the Journal of Recent Patents on A...
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery*

Article Details Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Cou...

Blog Archive

► 2018 (1)
- ► January (1)

▼ 2017 (34)
- ► November (1)
- ► October (3)
- ► September (2)
- ► August (3)
- ► July (4)
- ► June (3)
- ► May (3)
- ► April (3)
- ▼ March (4)
- ► February (2)
- ► January (6)

► 2016 (22)
- ► December (5)
- ► November (5)
- ► October (7)
- ► August (1)
- ► June (4)

Blogger templates

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery

Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women

Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion

Pages
- Home

Blogroll

About

Copyright © Recent Patents on AntiCancer Drug Discovery | Powered by Blogger

Design by NewWpThemes | Blogger Theme by Lasantha - Premium Blogger Templates | NewBloggerThemes.com